Literature DB >> 11773826

Effects of sevoflurane on electrocorticography in patients with intractable temporal lobe epilepsy.

Toshiki Endo1, Kiyotaka Sato, Hiroshi Shamoto, Takashi Yoshimoto.   

Abstract

Fentanyl-droperidol technique is the choice for epilepsy surgery. It requires intraoperative electrocorticography (ECoG), but a large dose of fentanyl is needed for this technique. On the other hand, sevoflurane reportedly may be beneficial for intraoperative ECoG. To reveal whether the combined technique with fentanyl and sevoflurane is beneficial for epilepsy surgery, we investigated ECoG in 10 patients with intractable temporal lobe epilepsy without sevoflurane, with 0.5 minimum alveolar concentration (MAC) sevoflurane, and with 1.5 MAC sevoflurane under fentanyl-based anesthesia. The mean number of spikes for 1 minute decreased from 38.3 to 14.1 after 1.5 MAC sevoflurane was induced, which was statistically significant ( P <.05). Our results showed that balanced technique with neurolepto-analgesia (NLA) and sevoflurane is not suitable for epilepsy surgery requiring intraoperative ECoG. When epilepsy surgeries are performed under sevoflurane anesthesia, it is important to consider that sevoflurane may suppress electric activities when it is used with other anesthetic agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773826     DOI: 10.1097/00008506-200201000-00012

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  2 in total

1.  Is intraoperative electrocorticography reliable in children with intractable neocortical epilepsy?

Authors:  Eishi Asano; Krisztina Benedek; Aashit Shah; Csaba Juhász; Jagdish Shah; Diane C Chugani; Otto Muzik; Sandeep Sood; Harry T Chugani
Journal:  Epilepsia       Date:  2004-09       Impact factor: 5.864

2.  Application of Awake Surgery for Epilepsy in Clinical Practice.

Authors:  Satoshi Maesawa; Daisuke Nakatsubo; Masazumi Fujii; Kentaro Iijima; Sachiko Kato; Tomotaka Ishizaki; Masashi Shibata; Toshihiko Wakabayashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-09-21       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.